Literature DB >> 17145164

The role of presence in virtual reality exposure therapy.

Matthew Price1, Page Anderson.   

Abstract

A growing body of literature suggests that virtual reality is a successful tool for exposure therapy in the treatment of anxiety disorders. Virtual reality (VR) researchers posit the construct of presence, defined as the interpretation of an artificial stimulus as if it were real, to be a presumed factor that enables anxiety to be felt during virtual reality exposure therapy (VRE). However, a handful of empirical studies on the relation between presence and anxiety in VRE have yielded mixed findings. The current study tested the following hypotheses about the relation between presence and anxiety in VRE with a clinical sample of fearful flyers: (1) presence is related to in-session anxiety; (2) presence mediates the extent that pre-existing (pre-treatment) anxiety is experienced during exposure with VR; (3) presence is positively related to the amount of phobic elements included within the virtual environment; (4) presence is related to treatment outcome. Results supported presence as a factor that contributes to the experience of anxiety in the virtual environment as well as a relation between presence and the phobic elements, but did not support a relation between presence and treatment outcome. The study suggests that presence may be a necessary but insufficient requirement for successful VRE.

Entities:  

Mesh:

Year:  2006        PMID: 17145164      PMCID: PMC3670421          DOI: 10.1016/j.janxdis.2006.11.002

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  8 in total

1.  Treatment of acrophobia in virtual reality: the role of immersion and presence.

Authors:  Merel Krijn; Paul M G Emmelkamp; Roeline Biemond; Claudius de Wilde de Ligny; Martijn J Schuemie; Charles A P G van der Mast
Journal:  Behav Res Ther       Date:  2004-02

2.  Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying.

Authors:  Barbara Olasov Rothbaum; Page Anderson; Elana Zimand; Larry Hodges; Delia Lang; Jeff Wilson
Journal:  Behav Ther       Date:  2006-02-24

3.  Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia.

Authors:  B O Rothbaum; L F Hodges; R Kooper; D Opdyke; J S Williford; M North
Journal:  Am J Psychiatry       Date:  1995-04       Impact factor: 18.112

4.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

5.  Emotional processing of fear: exposure to corrective information.

Authors:  E B Foa; M J Kozak
Journal:  Psychol Bull       Date:  1986-01       Impact factor: 17.737

Review 6.  Virtual reality exposure therapy of anxiety disorders: a review.

Authors:  M Krijn; P M G Emmelkamp; R P Olafsson; R Biemond
Journal:  Clin Psychol Rev       Date:  2004-07

7.  Anxiety and presence during VR immersion: a comparative study of the reactions of phobic and non-phobic participants in therapeutic virtual environments derived from computer games.

Authors:  Geneviève Robillard; Stéphane Bouchard; Thomas Fournier; Patrice Renaud
Journal:  Cyberpsychol Behav       Date:  2003-10

Review 8.  Computer-supported cognitive behavioral treatment of anxiety disorders.

Authors:  Page Anderson; Carli Jacobs; Barbara O Rothbaum
Journal:  J Clin Psychol       Date:  2004-03
  8 in total
  26 in total

1.  Does engagement with exposure yield better outcomes? Components of presence as a predictor of treatment response for virtual reality exposure therapy for social phobia.

Authors:  Matthew Price; Natasha Mehta; Erin B Tone; Page L Anderson
Journal:  J Anxiety Disord       Date:  2011-03-15

Review 2.  Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review.

Authors:  Cristina Botella; Javier Fernández-Álvarez; Verónica Guillén; Azucena García-Palacios; Rosa Baños
Journal:  Curr Psychiatry Rep       Date:  2017-07       Impact factor: 5.285

3.  Exposure and Response Prevention in Virtual Reality for Patients with Contamination-Related Obsessive-Compulsive Disorder: a Case Series.

Authors:  Franziska Miegel; Lara Bücker; Simone Kühn; Fariba Mostajeran; Steffen Moritz; Anna Baumeister; Luzie Lohse; Jannik Blömer; Karsten Grzella; Lena Jelinek
Journal:  Psychiatr Q       Date:  2022-07-02

Review 4.  Virtual Reality-Enhanced Extinction of Phobias and Post-Traumatic Stress.

Authors:  Jessica L Maples-Keller; Carly Yasinski; Nicole Manjin; Barbara Olasov Rothbaum
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  Virtual environments using video capture for social phobia with psychosis.

Authors:  Lina Gega; Richard White; Timothy Clarke; Ruth Turner; David Fowler
Journal:  Cyberpsychol Behav Soc Netw       Date:  2013-05-09

Review 6.  The impact of perception and presence on emotional reactions: a review of research in virtual reality.

Authors:  Julia Diemer; Georg W Alpers; Henrik M Peperkorn; Youssef Shiban; Andreas Mühlberger
Journal:  Front Psychol       Date:  2015-01-30

7.  Sense of presence and anxiety during virtual social interactions between a human and virtual humans.

Authors:  Nexhmedin Morina; Willem-Paul Brinkman; Dwi Hartanto; Paul M G Emmelkamp
Journal:  PeerJ       Date:  2014-04-03       Impact factor: 2.984

8.  The Relationship between Virtual Self Similarity and Social Anxiety.

Authors:  Laura Aymerich-Franch; René F Kizilcec; Jeremy N Bailenson
Journal:  Front Hum Neurosci       Date:  2014-11-19       Impact factor: 3.169

9.  The bilocated mind: new perspectives on self-localization and self-identification.

Authors:  Tiziano Furlanetto; Cesare Bertone; Cristina Becchio
Journal:  Front Hum Neurosci       Date:  2013-03-08       Impact factor: 3.169

10.  A meta-analysis on the relationship between self-reported presence and anxiety in virtual reality exposure therapy for anxiety disorders.

Authors:  Yun Ling; Harold T Nefs; Nexhmedin Morina; Ingrid Heynderickx; Willem-Paul Brinkman
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.